Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Regulation of the Hypothalamic‐Pituitary‐Adrenocortical Stress Response
Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., & Myers, B. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150015 · Cited by 1,819
“Notably, AVP is coreleased from CRH nerve terminals at the median eminence and works in conjunction with CRH to enhance the response during stress (60).”
Endocrinology of the stress response
Charmandari, E., Tsigos, C., & Chrousos, G. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120816 · Cited by 1,799
Stress hormones: their interaction and regulation
Axelrod, J., & Reisine, T. D. (1984) · Science · doi:10.1126/science.6143403 · Cited by 1,527
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
The effects of sex and hormonal status on the physiological response to acute psychosocial stress
Kajantie, E., & Phillips, D. I. W. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.07.002 · Cited by 1,035
“AVP is a nonapeptide produced by magnocellular neurons of the supraoptic and paraventricular nuclei of the hypothalamus with both peripheral, vasoconstrictor and antidiuretic, and neuroendocrine actions, including potentiation of CRH-evoked ACTH-release in the pituitary (Gillies et al., 1982).”
BackgroundThe stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“When released together into the portal capillaries, the ACTH-releasing activity of CRH is strongly potentiated by vasopressin (Gillies et al., 1982; Rivier and Vale, 1983).”
BackgroundUvnäs-Moberg, K. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00056-0 · Cited by 966
Stressor specificity of central neuroendocrine responses: implications for stress-related disorders
Pacák, K., & Palkovits, M. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0436 · Cited by 926
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
“…this response lies in the parvocellular division of the hypothalamic PVN, where neuronal populations producing corticorelin (CRH) and arginine vasopressin (AVP) coordinate the neuroendocrine, behavioral, autonomic, and immune responses to stress (Gillies et al., 1982; Charmandari et al., 2005).”
BackgroundSelf-citationEffects of stress on the immune system
Khansari, D. N., Murgo, A. J., & Faith, R. E. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90069-l · Cited by 668
Regulation of ACTH Secretion: Variations on a Theme of B
DALLMAN, M. F., AKANA, S. F., CASCIO, C. S., DARLINGTON, D. N., JACOBSON, L., & LEVIN, N. (1987) · Proceedings of the 1986 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571143-2.50010-1 · Cited by 655
Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress Exposure
van Bodegom, M., Homberg, J. R., & Henckens, M. J. A. G. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00087 · Cited by 562
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
Whitnall, M. H. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90035-q · Cited by 582
The stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
“When released together into the portal capillaries, AVP strongly potentiates the ACTH-releasing activity (Gillies et al., 1982; Rivier and Vale, 1983).”
BackgroundRivier, C., & Vale, W. (1983) · Nature · doi:10.1038/305325a0 · Cited by 539
Proopiomelanocortin Processing in the Pituitary, Central Nervous System, and Peripheral Tissues
SMITH, A. I., & FUNDER, J. W. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-159 · Cited by 540
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
Supramolecular Analytical Chemistry
Anslyn, E. V. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo0617971 · Cited by 492
Sawchenko, P. E., Swanson, L. W., & Vale, W. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1883 · Cited by 485
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473
“This potentiating effect was predicted by basic studies (Gillies et al. 1982), and it was suggested that the phenomenon of high post-CRH levels of ACTH and cortisol in dexamethasone-pretreated depressives is reflecting elevated AVP levels originating from the PVN and resulting in AVP-driven HPA…”
ResultAbnormal Hypothalamic–Pituitary–Adrenal Function in Anorexia Nervosa
Gold, P. W., Gwirtsman, H., Avgerinos, P. C., Nieman, L. K., Gallucci, W. T., Kaye, W., Jimerson, D., Ebert, M., Rittmaster, R., Loriaux, D. L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142102 · Cited by 454
Joëls, M., Sarabdjitsingh, R. A., & Karst, H. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005892 · Cited by 425
Mediation by Corticotropin Releasing Factor (CRF) of Adenohypophysial Hormone Secretion
Rivier, C. L., & Plotsky, P. M. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.002355 · Cited by 444
Purba, J. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020055007 · Cited by 433
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
“Although CRH is the primary ACTH secretagogue (7, 165, 177), the influence of the AVP/V1b receptor on the HPA axis response becomes more significant under certain stress conditions (8, 310, 429).”
BackgroundSheng, J. A., Bales, N. J., Myers, S. A., Bautista, A. I., Roueinfar, M., Hale, T. M., & Handa, R. J. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.601939 · Cited by 418
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 411
Physiological and pathological roles of interleukin-6 in the central nervous system
Gruol, D. L., & Nelson, T. E. (1997) · Molecular Neurobiology · doi:10.1007/bf02740665 · Cited by 404
Gonadal steroid hormones and the hypothalamo–pituitary–adrenal axis
Handa, R. J., & Weiser, M. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.11.001 · Cited by 408
“Nonetheless, both vasopressin and oxytocin can stimulate ACTH secretion even in the absence of CRF (Gillies et al., 1982; Schlosser et al., 1994) through the activation of the V1b receptor expressed by corticotrophs (Schlosser et al.”
BackgroundInfluentialRIVIER, C., & VALE, W. (1983) · Endocrinology · doi:10.1210/endo-113-3-939 · Cited by 406
Bao, A.-M., & Swaab, D. F. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.02.007 · Cited by 378
Stress, Visceral Obesity, and Metabolic Complications
KYROU, I., CHROUSOS, G. P., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.008 · Cited by 380
Suppression of hypothalmic-pituitary-adrenal axis responses to stress in lactating women
Altemus, M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.2954 · Cited by 382
Aguilera, G., & Rabadan-Diehl, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00196-8 · Cited by 375
Pediatric Stress: Hormonal Mediators and Human Development
Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003) · Hormone Research in Paediatrics · doi:10.1159/000069325 · Cited by 363
“CRH is permissive for secretion of adrenocorticotropin hormone (ACTH), whereas AVP has very little ACTH secretagogue activity despite the fact that it is a potent synergistic factor of CRH [”
BackgroundScott Young, W., Mezey, É., & Siegel, R. E. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90463-5 · Cited by 375
Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins
Smith, E. M., Morrill, A. C., Meyer, W. J., & Blalock, J. E. (1986) · Nature · doi:10.1038/321881a0 · Cited by 358
Weinberg, J., Sliwowska, J. H., Lan, N., & Hellemans, K. G. C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01669.x · Cited by 330
Characterization of rat hypothalamic corticotropin-releasing factor.
Rivier, J., Spiess, J., & Vale, W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4851 · Cited by 319
Kiss, J. Z., Mezey, E., & Skirboll, L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1854 · Cited by 304
Gold, P. W., & Chrousos, G. P. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.09423.x · Cited by 298
Brunton, P. J., Russell, J. A., & Douglas, A. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01735.x · Cited by 298
Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat
Sirinathsinghji, D. J. S., Rees, L. H., Rivier, J., & Vale, W. (1983) · Nature · doi:10.1038/305232a0 · Cited by 289
Lovejoy, D. A., & Balment, R. J. (1999) · General and Comparative Endocrinology · doi:10.1006/gcen.1999.7298 · Cited by 287
Scott, L. V., & Dinan, T. G. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00027-7 · Cited by 281
Patchev, V (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00096-6 · Cited by 283
Shanks, N., Larocque, S., & Meaney, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00376.1995 · Cited by 278
UDELSMAN, R., NORTON, J. A., JELENICH, S. E., GOLDSTEIN, D. S., LINEHAN, W. M., LORIAUX, D. L., & CHROUSOS, G. P. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-986 · Cited by 278
Kalsbeek, A., van Heerikhuize, J. J., Wortel, J., & Buijs, R. M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-17-05555.1996 · Cited by 274
“Numerous reports, however, have shown that VP from parvocellular and perhaps magnocellular PVN neurons has an excitatory instead of an inhibitory influence on HPA axis activity (Gillies et al., 1982; Rivier and Vale, 1983; De Goeij et al., 1992; Bernardini et al., 1994).”
BackgroundAguilera, G., Harwood, J. P., Wilson, J. X., Morell, J., Brown, J. H., & Catt, K. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82024-9 · Cited by 273
The Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
Spiga, F., Walker, J. J., Terry, J. R., & Lightman, S. L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c140003 · Cited by 267
“…afferent neural pathways, including those originating from limbic and brain-stem structures (196), which in turn induce the release of corticotropin-releasing hormone (CRH) and arginine vaso-pressin (AVP) from parvocellular neurons of the hypothalamic paraventricular nucleus (PVN) (62,159,167,197).”
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
Goh, G., Scholl, U. I., Healy, J. M., Choi, M., Prasad, M. L., Nelson-Williams, C., Kunstman, J. W., Korah, R., Suttorp, A.-C., Dietrich, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2956 · Cited by 251
Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T., Mori, T., & Tsujimoto, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19656 · Cited by 258
“(24), it was rapidly established that AVP potently synergizes with CRH to stimulate pituitary ACTH release; thus, when CRH and AVP are given together, ACTH output is well above the sum of that resulting from the two peptides alone in both rodents and humans (25, 26).”
Stress, Endocrine Physiology and Pathophysiology -- Endotext
DeGroot, L. J., Chrousos, G. P., Dungan, K., Grossman, A. B., Jm, H., Koch, C., Korbonits, M., McLachlan, R., New, M., Purnell, J. Q., et al. (2000) · Europe PMC (PubMed Central) · Cited by 301
Pathways to the Secretion of Adrenocorticotropin: A View from the Portal*
Plotsky, P. M. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00231.x · Cited by 258
Maturation and Activation of Hypothalamic-Pituitary Adrenal Function in Fetal Sheep*
CHALLIS, J. R. G., & BROOKS, A. N. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-2-182 · Cited by 259
PLOTSKY, P. M., & VALE, W. (1984) · Endocrinology · doi:10.1210/endo-114-1-164 · Cited by 259
Cole, R. L., & Sawchenko, P. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00959.2002 · Cited by 255
“These neurons can synthesize additional peptides, notably AVP, which synergize with CRF to determine pituitary–adrenal output (Gillies et al., 1982; Rivier and Vale, 1983; Hauger and Aguilera, 1993).”
BackgroundParaventricular Hypothalamic Mechanisms of Chronic Stress Adaptation
Herman, J. P., & Tasker, J. G. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00137 · Cited by 253
“While having minimal effects on its own, AVP can synergize with CRH to greatly amplify ACTH release (7).”
BackgroundPhysiological and Endocrine Effects of Social Contact
UVNÄS‐MOBERG, K. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51917.x · Cited by 250
Sysoev, V. V., Button, B. K., Wepsiec, K., Dmitriev, S., & Kolmakov, A. (2006) · Nano Letters · doi:10.1021/nl060185t · Cited by 252
Paracrinicity: The Story of 30 Years of Cellular Pituitary Crosstalk
Denef, C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01616.x · Cited by 244
Schlotz, W., Kumsta, R., Layes, I., Entringer, S., Jones, A., & Wüst, S. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181810658 · Cited by 237
“External application of corticotropin-releasing hormone (CRH) triggers HPA axis responses via pituitary CRH receptors, and arginine vasopressin (AVP) augments pituitary and adrenal responses to CRH stimulation (16,17).”
BackgroundEngler, D., Pham, T., Fullerton, M. J., Ooi, G., Funder, J. W., & Clarke, I. J. (2008) · Neuroendocrinology · doi:10.1159/000125141 · Cited by 235
Herman, J. P., Cullinan, W. E., & Watson, S. J. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00604.x · Cited by 235
“There was a significant effect of group on postoperative body weight gain (F(2, 17)=7.”
BackgroundResultInfluentialDissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress
Gibbs, D. M. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90241-8 · Cited by 233
Multifactorial regulation of the hypothalamic-pituitary-adrenal axis during development
Rosenfeld, P., Suchecki, D., & Levine, S. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80196-4 · Cited by 230
Whitnall, M. H., Mezey, Ė., & Gainer, H. (1985) · Nature · doi:10.1038/317248a0 · Cited by 231
Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release
Kalsbeek, A., Buijs, R. M., van Heerikhuize, J. J., Arts, M., & van der Woude, T. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)90927-2 · Cited by 226
Bertagna, X., Guignat, L., Groussin, L., & Bertherat, J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 222
Bartanusz, V. (1993) · Endocrinology · doi:10.1210/en.132.2.895 · Cited by 222
Bosch, O. J., Nair, H. P., Ahern, T. H., Neumann, I. D., & Young, L. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.154 · Cited by 216
“One possibility is that AVP released from the parvocellular neurons of the PVN may act synergistically with CRF on ACTH-containing cells of the pituitary under stressful conditions (Gillies et al, 1982; Aguilera, 1994).”
BackgroundLightman, S. L., & Young, W. S. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017261 · Cited by 215
Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1122 · Cited by 211
“A direct stimulating effect of AVP on corticotropin secretion in corticotroph cells has been extensively described both in vitro and in vivo (Gillies et al., 1982; Rivier and Vale, 1983; Antoni et al., 1984; Gaillard et al., 1984; Dickstein et al., 1996).”
BackgroundHanda, R. J., Pak, T. R., Kudwa, A. E., Lund, T. D., & Hinds, L. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.09.012 · Cited by 205
“Of particular importance, vasopressin, another neuropeptide found in PVN neurons, is also an ACTH secretogogue alone (Gillies et al, 1982) and it amplifies the actions of CRH at the level of the anterior pituitary corticotroph (Rivier and Vale, 1983, Schloser et al, 1994).”
BackgroundSawchenko, P. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-04-01093.1987 · Cited by 206
“While deoxycorticosterone is thought to be the principal endogenous mineralocorticoid in rat (Melby et al., 1972), its potency has been estimated to be 30-70-fold less than that of aldosterone (Gomer-Sanchez et al., 1976), and it does possess significant glucocorticoid activity.”
BackgroundGibbs, D. M., & Vale, W. (1983) · Brain Research · doi:10.1016/0006-8993(83)91189-7 · Cited by 205
Tsigos, C., & Chrousos, G. P. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30078-1 · Cited by 201
Hypothalamic-Pituitary-Adrenal Axis Modulation of Glucocorticoids in the Cardiovascular System
Burford, N., Webster, N., & Cruz-Topete, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102150 · Cited by 187
Corticotropin Releasing Hormone, Receptor Regulation and the Stress Response
Aguilera, G. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00079-4 · Cited by 195
High-Speed Fluorescence Detection of Explosives-like Vapors
Albert, K. J., & Walt, D. R. (2000) · Analytical Chemistry · doi:10.1021/ac991397w · Cited by 197
Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis
Christ-Crain, M., & Fenske, W. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.224 · Cited by 189
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review
Gibbs, D. M. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90048-x · Cited by 192
Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities
Rigney, N., de Vries, G. J., Petrulis, A., & Young, L. J. (2022) · Endocrinology · doi:10.1210/endocr/bqac111 · Cited by 191
Herman, J. P., Nawreen, N., Smail, M. A., & Cotella, E. M. (2020) · Stress · doi:10.1080/10253890.2020.1859475 · Cited by 170
“, arginine vasopressin (AVP) that enhance the efficacy of down-stream CRH action (Gillies et al., 1982).”
BackgroundDeBold, C. R., Sheldon, W. R., DeCherney, G. S., Jackson, R. V., Alexander, A. N., Vale, W., Rivier, J., & Orth, D. N. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111240 · Cited by 189
The origin of glucocorticoid hormone oscillations
Walker, J. J., Spiga, F., Waite, E., Zhao, Z., Kershaw, Y., Terry, J. R., & Lightman, S. L. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001341 · Cited by 189
“Central regulation of glucocorticoid secretion is predominantly coordinated by the hypothalamic peptide corticotrophin-releasing hormone (CRH) [6,7], the efficacy of which can be significantly potentiated by other hypothalamic factors, most notably vasopressin [8].”
BackgroundSawchenko, P. E. (1987) · Brain Research · doi:10.1016/0006-8993(87)90058-8 · Cited by 189
Copeptin: A Biomarker of Cardiovascular and Renal Function
Morgenthaler, N. G. (2010) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2010.00177.x · Cited by 181
Chrousos, G. P. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30191-9 · Cited by 182
CSF corticotropin-releasing hormone in depressed patients and normal control subjects
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.5.641 · Cited by 183
de Goeij, D. C. E., Jezova, D., & Tilders, F. J. H. (1992) · Brain Research · doi:10.1016/0006-8993(92)90552-k · Cited by 181
Ma, X.-M. (1999) · Endocrinology · doi:10.1210/en.140.8.3623 · Cited by 182
Nickel, C. H., Bingisser, R., & Morgenthaler, N. G. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-7 · Cited by 169
“Corticotropin-releasing hormone and AVP appear to have a synergistic effect, resulting in adrenocorticotropic hormone (ACTH) and cortisol release [4-7].”
Ma, X.-M., Levy, A., & Lightman, S. L. (1997) · Endocrinology · doi:10.1210/endo.138.10.5446 · Cited by 171
Ma, X., & Lightman, S. L. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.605bk.x · Cited by 177
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.